2-[3-(Pyridin-1-ium-2-yl)-1H-pyrazol-1yl]-6-[3-(pyridin-2-yl)-1H-pyrazol-1-yl]pyridinium sulfate methanol monosolvate

被引:0
|
作者
Huang, Linxia [1 ]
Shu, Mouhai [1 ]
机构
[1] Shanghai Jiao Tong Univ, Sch Chem & Chem Engn, State Key Lab Met Matrix Composites, Shanghai 200240, Peoples R China
关键词
single-crystal X-ray study; T = 293 K; mean sigma(C-C) = 0.005 angstrom; disorder in solvent or counterion; R factor = 0.053; wR factor = 0.163; data-to-parameter ratio = 12.6;
D O I
10.1107/S1600536813008647
中图分类号
O7 [晶体学];
学科分类号
0702 ; 070205 ; 0703 ; 080501 ;
摘要
The title solvated salt, C21H17N7 2+·SO4 2-·CH3OH, was obtained when we attempted to prepare the complex of ferrous sulfate and 2,6-bis[3-(pyridin-2-yl)-1H-pyrazol-1-yl]pyridine in methanol. The dihedral angles between adjacent pyridine and pyrazole rings range from 3.8 (1) to 13.4 (1)°. An intramolecular N - H⋯N hydrogen bond occurs. In the crystal, N - H⋯O and O - H⋯N hydrogen bonds between solvent methanol molecules and the cations generate zigzag chains along [110].
引用
收藏
页码:O689 / +
页数:8
相关论文
共 50 条
  • [21] Bis[3-methyl-5-(pyridin-2-yl)-1H-pyrazol-4-yl] selenide methanol hemisolvate
    Seredyuk, Maksym
    Sharkina, Natalia O.
    Gumienna-Kontecka, Elzbieta
    Kapshuk, Anatoly A.
    ACTA CRYSTALLOGRAPHICA SECTION E-CRYSTALLOGRAPHIC COMMUNICATIONS, 2014, 70 : 0127 - +
  • [22] Hydrothermal syntheses and characterization of a series of mixed-ligand luminescent CdII frameworks with novel 2-(3-(pyridin-2-yl)-1H-pyrazol-1-yl) acetate ligand and benzenedicarboxylate isomers
    Cai, Hua
    Guo, Ying
    Li, Jian-Gang
    INORGANIC CHEMISTRY COMMUNICATIONS, 2013, 34 : 37 - 41
  • [23] Crystal structure of 3-(6-(5-amino-1-phenyl-1H-pyrazol-3-yl)pyridin-2-yl)-1-phenyl-1H-pyrazol-5-amine-dioxan (2/1), C25H23N7O
    Amr, Abd El-Galil E.
    Al-Omar, Mohamed A.
    Khalifa, Nagy M.
    Ghabbour, Hazem A.
    Ali, Korany K.
    ZEITSCHRIFT FUR KRISTALLOGRAPHIE-NEW CRYSTAL STRUCTURES, 2016, 231 (02): : 597 - 599
  • [24] Crystal structure of bis{3-(3,4-dimethylphenyl)-5-[6-(1H-pyrazol-1-yl)pyridin-2-yl]-4H-1,2,4-triazol-4-ido}iron(II) methanol disolvate
    Znovjyak, Kateryna
    Fritsky, Igor O.
    Sliva, Tatiana Y.
    Amirkhanov, Vladimir M.
    Malinkin, Sergey O.
    Shova, Sergiu
    Seredyuk, Maksym
    ACTA CRYSTALLOGRAPHICA SECTION E-CRYSTALLOGRAPHIC COMMUNICATIONS, 2022, 78 : 1107 - +
  • [25] Crystal structure of 3-{5-[3-(4-fluorophenyl)-1-isopropyl-1H-indol-2-yl]-1H-pyrazol-1-yl}indolin-2-one ethanol monosolvate
    Rahman, Md. Lutfor
    Kulkarni, Ajaykumar D.
    Yusoff, Mashitah Mohd.
    Kwong, Huey Chong
    Quah, Ching Kheng
    ACTA CRYSTALLOGRAPHICA SECTION E-CRYSTALLOGRAPHIC COMMUNICATIONS, 2016, 72 : 283 - +
  • [26] Pharmacologically active 2-(1H-pyrazol-1-yl)acetamides
    Zalaru, Christina
    Dumitrascu, Florea
    Draghici, Constantin
    Cristea, Elena
    Tarcomnicu, Isabela
    ARKIVOC, 2009, : 308 - 314
  • [27] 3-(2-Oxo-2H-pyridin-1-yl)phthalonitrile
    Xue, Jin-Ping
    Zhu, Hua-Li
    Chen, Nai-Sheng
    Huang, Jin-Ling
    ACTA CRYSTALLOGRAPHICA SECTION E-STRUCTURE REPORTS ONLINE, 2007, 63 : O2434 - U799
  • [28] [1-Methoxy-3-(pyridin-2-yl)indolizin-2yl](pyridin-2-yl)methanone
    Kloubert, Tobias
    Kretschmer, Robert
    Goerls, Helmar
    Westerhausen, Matthias
    ACTA CRYSTALLOGRAPHICA SECTION E-CRYSTALLOGRAPHIC COMMUNICATIONS, 2012, 68 : O2631 - +
  • [29] 2-Phenyl and 2-heterocyclic-4-(3-(pyridin-2-yl)-1H-pyrazol-4-yl)pyridines as inhibitors of TGF-β1 and activin A signalling
    Ciayadi, Rudy
    Potdar, Mahesh
    Walton, Kelly L.
    Harrison, Craig A.
    Kelso, Geoffrey F.
    Harris, Simon J.
    Hearn, Milton T. W.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2011, 21 (18) : 5642 - 5645
  • [30] Synthesis and antimicrobial screening of some 3-[4-(3-aryl-1-phenyl-1H-pyrazol-4-yl)-6-aryl-pyridin-2-yl] and 4-methyl-3-phenyl-6-[4-(3-aryl-1-phenyl-1H-pyrazol-4-yl)-6-aryl-pyridin-2-yl] coumarins
    Brahmbhatt, D. I.
    Kaneria, Ankit R.
    Patel, Anil K.
    Patel, Niraj H.
    INDIAN JOURNAL OF CHEMISTRY SECTION B-ORGANIC CHEMISTRY INCLUDING MEDICINAL CHEMISTRY, 2010, 49 (07): : 971 - 977